Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study

被引：0

作者：

Shadman, Mazyar ^{[1
]}

Sail, Kavita ^{[2
]}

Manzoor, Beenish S. ^{[2
]}

Yazdy, Maryam Sarraf ^{[3
]}

Hill, Brian T. ^{[4
]}

Tuncer, Hande H. ^{[5
]}

Allan, John N. ^{[6
]}

Ujjani, Chaitra S. ^{[1
]}

Emechebe, Nnadozie ^{[2
]}

Kamalakar, Rajesh ^{[2
]}

Sharmokh, Simon ^{[2
]}

Jiang, Daniel Dingfeng ^{[2
]}

Pena, German ^{[2
]}

Marshall, Thomas ^{[2
]}

Nielsen, Jacqueline ^{[2
]}

Barr, Paul M. ^{[7
]}

Brown, Jennifer R. ^{[8
]}

Schuh, Anna ^{[9
]}

Eyre, Toby A. ^{[9
]}

Lamanna, Nicole ^{[10
]}

Wierda, William G. ^{[11
]}

Skarbnik, Alan ^{[12
]}

Roeker, Lindsey E. ^{[13
]}

Bannerji, Rajat ^{[14
]}

Pauff, James M. ^{[2
]}

Schuster, Stephen J. ^{[15
]}

Follows, George A. ^{[16
]}

Cheson, Bruce D. ^{[17
]}

Eichhorst, Barbara F. ^{[18
]}

Brander, Danielle M. ^{[19
]}

Pivneva, Irina ^{[20
]}

Guerin, Annie ^{[20
]}

Mato, Anthony R. ^{[13
,21
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[2] AbbVie Inc, N Chicago, IL USA

[3] Georgetown Univ Hosp, Washington, DC 20007 USA

[4] Cleveland Clin, Cleveland, OH 44106 USA

[5] Lowell Gen Hosp, Ctr Canc, Lowell, MA USA

[6] Weill Cornell Med Univ, Med Ctr, New York, NY USA

[7] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA

[8] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[9] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford, England

[10] Columbia Univ, New York, NY USA

[11] MD Anderson Canc Ctr, Houston, TX USA

[12] Novant Hlth, Charlotte, NC USA

[13] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, CLL Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[14] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

[15] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[16] Cambridge Univ Hosp NHS Trust, Cambridge, England

[17] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[18] Univ Cologne, Dept Internal Med, Ctr Integrated Oncol Koln Bonn, Cologne, Germany

[19] Duke Univ, Med Ctr, Duke Canc Ctr, Durham, NC USA

[20] Anal Grp, Montreal, PQ, Canada

[21] Mem Sloan Kettering Canc Ctr, Hematol Malignancies Div, CLL Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-131401

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3048

引用

页数：7

共 50 条

[31] Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study
Gupta, Vikas
Tomuleasa, Ciprian
Lampon, Gilberto Israel Barranco
Hou, Hsin-An
Helbig, Grzegorz
Vachhani, Pankit
Symeonidis, Argiris
Haznedaroglu, Ibrahim
Galvez, Kenny
Tatsch, Fernando
Chopra, Avijeet S.
Zhang, Meng
Vizkelety, Tamas
Murray, Bryan
Ross, David M.
BLOOD ADVANCES, 2025, 9 (05) : 1105 - 1116
[32] Homozygous familial hypercholesterolemia in China: Genetic and clinical characteristics from a real-world, multi-center, cohort study
Jiang, Long
Stoekenbroek, Robert M.
Zhang, Feng
Wang, Qian
Yu, Wei
Yuan, Hui
Cai, Gaojun
Chen, Yunqin
Li, Guoping
Yang, Yanling
Zhang, Yanan
Cheng, Xiaoshu
Zhu, Handong
Zhou, Hongwen
Ye, Ping
Yan, Shengkai
Wang, Xu
Wu, Wenfeng
Li, Rongjuan
Xie, Jinjie
Jiao, Jian
Cheng, Shitong
Niu, Wenquan
Chen, Juan
Yang, Shiwei
Zhou, Yujie
Kastelein, John J. P.
Yang, Ya
Wang, Luya
JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (03) : 306 - 314
[33] Real-World Effectiveness of Cladribine Tablets in Individuals with Multiple Sclerosis: Data from a Multi-Center Italian Study
Lucchini, Matteo
Borriello, Giovanna
Haggiag, Shalom
Nicoletti, Carolina
Fantozzi, Roberta
Buscarinu, Maria Chiara
Ferrazzano, Gina
Cortese, Antonio
Marinelli, Fabiana
Monteleone, Fabrizia
Centonze, Diego
Conte, Antonella
Ferraro, Elisabetta
Gasperini, Claudio
Marfia, Girolama Alessandra
Pozzilli, Carlo
Salvetti, Marco
Barbuti, Elena
Bianco, Assunta
Carlomagno, Vincenzo
Cruciani, Alessandro
De Giglio, Laura
Dionisi, Claudia
Ianniello, Antonio
Malimpensa, Leonardo
Nasello, Martina
Nociti, Viviana
Prosperini, Luca
Tortorella, Carla
Mirabella, Massimiliano
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 376 - 377
[34] Real-world effectiveness of upadacitinib for perianal Crohn's disease: A multi-center retrospective study
Devi, J.
Quraishi, B.
Dev, B.
Kline, M.
Jaiprada, F.
Huang, K.
Khan, A.
Alanazi, S.
Seeraj, A. A.
Maas, L.
Jajoo, A.
Chowla, N.
Stone, M.
Patel, A.
Xu, A.
Shukla, R.
Bishu, S.
Johnson, A. L.
Parian, A.
Yarur, A.
Mccurdy, J.
Mcdonald, B. D.
Wong, S. Y.
Deepak, P.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1645 - i1647
[35] A Multi-Center Real-World Study of Clinicopathologic Characteristics and Efficacy of the Malignant Mesothelioma in Chinese Population
Sun, Chenrui
Yang, Xue
Chen, Lan
Bie, Zhixin
Kang, Runting
Ai, Bin
Ma, Junling
Zheng, Zitong
Liu, Haolan
Liu, Juanjuan
Zhong, Jia
Yu, Jiangyong
THORACIC CANCER, 2025, 16 (03)
[36] COMPARATIVE EFFICACY OF ISCGM, RTCGM, AND SMBG AMONG PATIENTS WITH TYPE 1 DIABETES: REAL-WORLD EVIDENCE FROM A MULTI-CENTER STUDY
Hsieh, S.
Ebekozien, O.
Rioles, N.
Ospelt, E.
Majidi, S.
Akturk, H.
Buckingham, D.
Miyazaki, B.
Jones, N. Hawa Yayah
Mcdonough, R.
Demeterco-Berggren, C.
Jacobson, L.
Noor, N.
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A33 - A33
[37] Contemporary real-world treatment patterns of chronic lymphocytic leukaemia (CLL) in England
Blak, B. T.
Hori, S.
Lock, K.
Livings, C.
Chen, C.
Yong, A. S. M.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 213 - 214
[38] DO REAL-WORLD TREATMENT PATTERNS REFLECT PSA RECOMMENDATIONS? RESULTS FROM THE PROSPIRIT STUDY
Tillett, William
Nisar, Muhammad
Chandran, Vinod
Ng, Khai Jing
Ngantcha, Marcus
Laedermann, Cedric
Moyano, Sebastian
Alten, Rieke
Kristensen, Lars Erik
Mcgonagle, Dennis
ACTA DERMATO-VENEREOLOGICA, 2024, 104
[39] REAL-WORLD EFFECTIVENESS AND TREATMENT PATTERNS OF VENETOCLAX-BASED REGIMENS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN COMMUNITY SETTINGS
Zakeri, M.
Emechebe, N.
Chowdhery, R.
Jawaid, D.
Alhasani, H.
Manzoor, B. S.
VALUE IN HEALTH, 2023, 26 (06) : S54 - S55
[40] Comparable outcomes in CLL patients treated with reduced-dose ibrutinib: Results from a multi-center study.
Timlin, Colleen
Banerjee, Rahul
Howlett, Christina
Ujjani, Chaitra Shankar
Skarbnik, Alan P.
Fanning, Molly
Schuster, Stephen J.
Svoboda, Jakub
Porter, David L.
Nasta, Sunita
Stadtmauer, Edward A.
Landsburg, Daniel Jeffrey
Feldman, Tatyana
Rago, Allison
Dorsey, Colleen
Capozzi, Donna L.
Morganroth, Jennifer
Goy, Andre
Cheson, Bruce D.
Mato, Anthony R.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

← 1 2 3 4 5 →